作者:
Bi,V. [1]
;
Jawa,V. [2]
;
Joubert,M.K. [3]
;
Kaliyaperumal,A. [4]
;
Eakin,C. [5]
;
Richmond,K. [6]
;
Pan,O. [7]
;
Sun,J. [8]
;
Hokom,M. ;
Goletz,T.J. ;
Wypych,J. ;
Zhou,L. ;
Kerwin,B.A. ;
Narhi,L.O. ;
Arora,T.
作者单位:
The Department of Clinical Immunology, Amgen Inc., Thousand Oaks, CA, United States
[1]
The Department of Clinical Immunology, Amgen Inc, Seattle, WA, United States
[2]
The Department of Medical Sciences, Amgen Inc, Thousand Oaks, CA, United States
[3]
Antibody Development, NGM Biopharmaceuticals, South San Francisco, CA, United States
[4]
The Department of Therapeutic Discovery, Amgen Inc., Thousand Oaks, CA, United States
[5]
The Department of Therapeutic Discovery, Amgen Inc, Burnaby, Canada
[6]
The Department of Process and Product Development, Amgen Inc., Thousand Oaks, CA, United States
[7]
The Department of Process and Product Development, Amgen Inc, Seattle, WA, United States
[8]
发布时间
2014-01-21